La Asociación Duchenne Parent Project España (DPPE, www.duchenne-spain.org) y la compañía Biofarmacéutica SOM Biotech han llegado a un acuerdo de colaboración para llevar a cabo el proyecto “Reposicionamiento de Fármacos para la Distrofia Muscular de Duchenne (DMD)”. El equipo de SOM Biotech será el encargado de la identificación in silico de compuestos activos frente a…
ACUERDO DE COLABORACIÓN ENTRE DUCHENNE PARENT PROJECT ESPAÑA Y SOM BIOTECH.
posted on February 10, 2017
JPMORGAN HEALTCARE CONFERENCE 2017
posted on January 30, 2017
SOM Biotech will attend next JP Morgan Healthcare Conference 2017. This event will take place in San Francisco, CA from January 9-12, 2017. If you are interested in meeting SOM Biotech delegates and knowing more about SOM's current programs, send an email to [email protected] to arrange a meeting. In addition, SOM Biotech delegates will also be attending the 9th…
SOM BIOTECH closes a €2M financing round
posted on January 17, 2017
The clinical-stage pharmaceutical company SOM Biotech, focused in repositioning drugs in orphan CNS indications, has just closed a €2M euros financing round led by investor from a Monaco based private investment firm.
SOM BIOTECH PRESENTING AT MID-ATLANTIC BIO ANGELS
posted on December 10, 2016
Dr. Raúl Insa, SOM Biotech CEO, will be presenting the company at MABA (Mid-Atlantic Bio Angels) Forum. This event will take place in New York (US) on December 13th. Further information at http://bioangels.net/index.php
B-DEBATE ON DRUG REPURPOSING FOR RARE DISEASES
posted on November 10, 2016
Dr. Raúl Insa, SOM Biotech CEO, will be one of the speakers at next B-Debate on 'Drug Repurposing for Rare Diseases. The Cure for the 21st Century'. Barcelona 17th and 18th November 2016. Further information at B-Debate Barcelona
SOM BIOTECH AT BIO-EUROPE 2016 (COLOGNE, NOVEMBER 7-9)
posted on October 10, 2016
SOM Biotech will attend next BIO-Europe, Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. It is regarded as a “must attend” event for the biotech industry. This event will take place in Cologne from 7-9 November 2016.…